Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors.

Human adenosine A2A and rat dopamine D2 receptors (A2A and D2 receptors) were co-transfected in Chinese hamster ovary (CHO) cells to study the interactions between two receptors that are co-localized in striatopallidal gamma-aminobutyric acid-(GABA)ergic neurons. Membranes from transfected cells showed a high density of D2 (3.6 pmol per mg protein) and A2A receptors (0.56 pmol per mg protein). The D2 receptors were functional: an agonist, quinpirole, could stimulate GTPgammaS binding and reduce stimulated adenylyl cyclase activity. The A2A receptor agonist 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680) decreased high-affinity binding of the agonist dopamine at D2 receptors. Activation of adenosine A2A receptors shifted the dose-response curve for quinpirole on adenosine 3',5'-cyclic monophosphate (cAMP) to the right. However, CGS 21680 did not affect dopamine D2 receptor-induced GTPgammaS binding, but did cause a concentration-dependent increase in cAMP accumulation. The maximal cAMP response was decreased by the D2 agonist quinpirole in a concentration-dependent manner, but there was no change in EC50 and no effect in cells transfected only with adenosine A2A receptors. A2A receptor activation also increased phosphorylation of cAMP response element-binding protein and expression of c-fos mRNA. These effects were also strongly counteracted by quinpirole. These results show that the antagonistic actions between adenosine A2A and dopamine D2 receptors noted previously in vivo can also be observed in CHO cells where the two receptors are co-transfected. Thus, no brain cell-specific factors are required for such interactions. Furthermore, the interaction at the second messenger level and beyond may be quantitatively more important than A2A receptor-mediated inhibition of high affinity D2 agonist binding to the receptor.

[1]  Sergi Ferré,et al.  Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia , 1997, Trends in Neurosciences.

[2]  B B Fredholm,et al.  Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells. , 1996, European journal of pharmacology.

[3]  B B Fredholm,et al.  Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Gebicke-haerter,et al.  Molecular mechanisms of microglial activation. A. Implications for regeneration and neurodegenerative diseases. , 1996, Neurochemistry international.

[5]  B. Fredholm,et al.  Pharmacology of adenosine A2A receptors. , 1996, Trends in pharmacological sciences.

[6]  P. Greengard,et al.  Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms , 1999, Neuroscience.

[7]  C. Konradi,et al.  Amphetamine regulates gene expression in rat striatum via transcription factor CREB , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  P. Svenningsson,et al.  Regional differences in the ability of caffeine to affect haloperidol-induced striatal c-fos mRNA expression in the rat , 1998, Neuropharmacology.

[9]  A M Graybiel,et al.  Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  P. Greengard,et al.  Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons , 1998, Neuroscience.

[11]  U. Ungerstedt,et al.  The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  B. Fredholm,et al.  Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat , 1994, Neuroscience.

[13]  B. Bloch,et al.  Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Vanderhaeghen,et al.  Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  P J Richardson,et al.  Desensitisation of the Adenosine A1 Receptor by the A2A Receptor in the Rat Striatum , 1997, Journal of neurochemistry.

[16]  Masatoshi Hagiwara,et al.  Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.

[17]  T. Kenakin,et al.  Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry. , 1997, Trends in pharmacological sciences.

[18]  B. Fredholm,et al.  A2a/D2 receptor interactions are not observed in COS-7 cells transiently transfected with dopamine D2 and adenosine A2a receptor cDNA. , 1994, Biochemical pharmacology.

[19]  S. Hourani,et al.  Adenosine receptor subtypes. , 1993, Trends in pharmacological sciences.

[20]  J. Yates,et al.  A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus , 1985, Molecular and cellular biology.

[21]  B. Fredholm,et al.  A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. , 1990, Analytical biochemistry.

[22]  G. Di Chiara,et al.  Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. , 1994, European journal of pharmacology.

[23]  B. Fredholm,et al.  Differences in the order of potency for agonists but not antagonists at human and rat adenosine A2A receptors. , 1999, Biochemical pharmacology.

[24]  B B Fredholm,et al.  Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine. , 1995, Pharmacology & toxicology.

[25]  K. Fuxe,et al.  Adenosine-dopamine interactions in the brain , 1992, Neuroscience.

[26]  P. Svenningsson,et al.  Dopamine–Adenosine Interactions in the Striatum and the Globus Pallidus: Inhibition of Striatopallidal Neurons through Either D2 or A2A Receptors Enhances D1Receptor-Mediated Effects on c-fos Expression , 1997, The Journal of Neuroscience.

[27]  C. Gerfen The neostriatal mosaic: multiple levels of compartmental organization , 1992, Trends in Neurosciences.

[28]  S. Schiffmann,et al.  Striatal Restricted Adenosine A2 Receptor (RDC8) Is Expressed by Enkephalin but Not by Substance P Neurons: An In Situ Hybridization Histochemistry Study , 1991, Journal of neurochemistry.

[29]  E. Ongini,et al.  Binding of the radioligand [3H]‐SCH 58261, a new non‐xanthine A2A adenosine receptor antagonist, to rat striatal membranes , 1996, British journal of pharmacology.

[30]  Richard J Smeyne,et al.  Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements , 1995, Neuron.

[31]  C. Gerfen,et al.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.

[32]  E. Borrelli,et al.  Signal transduction and gene control: the cAMP pathway. , 1992, Critical reviews in oncogenesis.

[33]  E. M. Adler,et al.  Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. , 1992, Brain research. Molecular brain research.

[34]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[35]  P. Svenningsson,et al.  Caffeine mimics the effect of a dopamine D 2 3 receptor agonist on the expression of immediate early genes in globus pallidus , 1997, Neuropharmacology.

[36]  P. Svenningsson,et al.  Biphasic changes in locomotor behavior and in expression of mRNA for NGFI-A and NGFI-B in rat striatum following acute caffeine administration , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  P. Svenningsson,et al.  Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate–putamen and nucleus accumbens , 1997, Neuroscience.

[38]  P. Svenningsson,et al.  Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons , 1999, Neuroscience.

[39]  M. Karin Signal transduction and gene control. , 1991, Current opinion in cell biology.

[40]  R. Maurer,et al.  An Inactivating Point Mutation Demonstrates That Interaction of cAMP Response Element Binding Protein (CREB) with the CREB Binding Protein Is Not Sufficient for Transcriptional Activation (*) , 1995, The Journal of Biological Chemistry.

[41]  T. Curran,et al.  Isolation and characterization of the c-fos(rat) cDNA and analysis of post-translational modification in vitro. , 1987, Oncogene.

[42]  P. Svenningsson,et al.  Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas , 1997, Neuroscience.

[43]  G. Chiara,et al.  Blockade of A2a Adenosine Receptors Positively Modulates Turning Behaviour and c‐Fos Expression Induced by D1 Agonists in Dopamine‐denervated Rats , 1996, The European journal of neuroscience.

[44]  G. Stiles,et al.  Adenosine receptor subtypes: characterization and therapeutic regulation. , 1995, Annual review of pharmacology and toxicology.